Journal of Chinese Pharmaceutical Sciences ›› 2023, Vol. 32 ›› Issue (7): 527-538.DOI: 10.5246/jcps.2023.07.044
• Original articles • Previous Articles Next Articles
Dongyan Wu, Xiaodan Wang, Jinmiao Chai*(), Qinqing Li, Yue Li, Mei Bi, Wanwei Gui, Huimin Cao
Received:
2022-10-27
Revised:
2022-11-24
Accepted:
2022-12-26
Online:
2023-07-31
Published:
2023-07-31
Contact:
Jinmiao Chai
Supporting:
Dongyan Wu, Xiaodan Wang, Jinmiao Chai, Qinqing Li, Yue Li, Mei Bi, Wanwei Gui, Huimin Cao. Study on the mechanism of Danggui Buxue decoction in the treatment of diabetic retinopathy based on network pharmacology and experiment[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(7): 527-538.
[1] |
Sabanayagam, C.; Banu, R.; Chee, M.L.; Lee, R.; Wang, Y.X.; Tan, G.; Jonas, J.B.; Lamoureux, E.L.; Cheng, C.Y.; Klein, B.E.K.; Mitchell, P.; Klein, R.; Cheung, C.M.G.; Wong, T.Y. Incidence and progression of diabetic retinopathy: a systematic review. Lancet Diabetes Endocrinol. 2019, 7, 140–149.
|
[2] |
Wan, W.C.; Long, Y. Current research on the epidemiology, etiology and pathogenesis of diabetic retinopathy. New Adv. Ophthalmol. 2022, 42, 673–679.
|
[3] |
Jiao, J.J.; Chang, K.; Yao, W.Y.; Zhang, Q.H.; Li, X.P. Exploring the mechanism of action of resveratrol in the treatment of diabetic retinopathy based on network pharmacology and experimental validation. Modern Drugs Clin. 2022, 37, 942–951.
|
[4] |
Li, D.Y. Discourse on the identification and confusion of internal and external injuries. Beijing: China Medical Science and Technology Press. 2016, 40.
|
[5] |
Sun, X.H.; Qian, K.W.; Zhou, Y.; Gu, H.Y. Study on the efficacy and mechanism of Angelica Sinensis Blood Tonic Tang Plus for diabetic retinopathy. J. Modern Int. Chin. Western Med. 2019, 28, 3152–3155, 3170.
|
[6] |
Tang, Z.Z. Study on the mechanism of protection of BRB in diabetic rats by angelica blood tonic soup through Müller cell pathway. Shanxi Univ. Tradit. Chin. Med. 2021.
|
[7] |
Yang, F.X.; Wang, Y.; Xia, P.F.; Yang, R.J.; Wang, Y.X.; Zhang, J.; Fan, Q.; Zhao, L. Research progress on chemical composition, pharmacological effects, clinical application and predictive analysis of quality markers of angelica blood tonic soup. Chin. J. Tradit. Chin. Med. 2021, 46, 2677–2685.
|
[8] |
Zhang, Y.X. Clinical study on the treatment of non-proliferative diabetic retinopathy with the addition formula of Danggui Buxue decoction. Fujian Univ. Tradi. Chin. Med. 2015.
|
[9] |
Deng, C.; Li, J.; Tang, X.Z. Effect of addition and subtraction of Danggui Buxue decoction on the efficacy of diabetic retinopathy and the effect of serum ICAM-1 and ET-1 levels. Chin. Med. Inform. 2018, 35, 90–93.
|
[10] |
Chai, G.R.; Liu, S.; Yang, H.W.; Chen, X.L. Quercetin protects against diabetic retinopathy in rats by inducing heme oxygenase-1 expression. Neural Regen. Res. 2021, 16, 1344–1350.
|
[11] |
Lupo, G.; Cambria, M.T.; Olivieri, M.; Rocco, C.; Caporarello, N.; Longo, A.; Zanghì, G.; Salmeri, M.; Foti, M.C.; Anfuso, C.D. Anti-angiogenic effect of quercetin and its 8-methyl pentamethyl ether derivative in human microvascular endothelial cells. J. Cell Mol. Med. 2019, 23, 6565–6577.
|
[12] |
Pratiwi, R.; Nantasenamat, C.; Ruankham, W.; Suwanjang, W.; Prachayasittikul, V.; Prachayasittikul, S.; Phopin, K. Mechanisms and neuroprotective activities of stigmasterol against oxidative stress-induced neuronal cell death via sirtuin family. Front. Nutr. 2021, 8, 648995.
|
[13] |
Wang, J.; Gong, H.M.; Zou, H.H.; Liang, L.; Wu, X.Y. Isorhamnetin prevents H2O2‑induced oxidative stress in human retinal pigment epithelial cells. Mol. Med. Rep. 2018, 17, 648–652.
|
[14] |
Hu, N.N.; Zhang, X.J. Progress of research on chemical composition and pharmacological effects of Astragalus membranaceus. Chin. Med. Inform. 2021, 38, 76–82.
|
[15] |
Zhang, C.C.; Yin, Y.; Nie, S.Q.; Zheng, Y.J. The effect of inflammation on neurodegenerative changes in diabetic retinopathy. J. Clin. Ophthalmol. 2019, 27, 378–382.
|
[16] |
Yan, P.; Zhang, X.H.; Zhang, L.; Li, J. Study on the relationship between HMW-ADP, TNF-α, VEGF and diabetic retinopathy. Chin. Med. Herald. 2019, 16, 106–109.
|
[17] |
Koleva-Georgieva, D.N.; Sivkova, N.P.; Terzieva, D. Serum inflammatory cytokines IL-1beta, IL-6, TNF-α and VEGF have influence on the development of diabetic retinopathy. Folia Med. 2011, 53, 44–50.
|
[18] |
Le, Y.Z. VEGF production and signaling in Müller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases. Vis. Res. 2017, 139, 108–114.
|
[19] |
Wang, Y.R.; Tang, Z.Z.; Li, Y.; Wu, D.Y.; Li, Q.Q.; Chai, J.M. Balancing relationships in diabetic retinopathy based on the theory of yin and yang. Lishizhen Med. Materia Medica Res. 2021, 32, 1704–1706.
|
[20] |
Nian, S.; Lo, A.C.Y.; Mi, Y.; Ren, K.; Yang, D. Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets. Eye Vis. Lond. Engl. 2021, 8, 15.
|
[21] |
Elsherbiny, N.M.; Abdel-Mottaleb, Y.; Elkazaz, A.Y.; Atef, H.; Lashine, R.M.; Youssef, A.M.; Ezzat, W.; El-Ghaiesh, S.H.; Elshaer, R.E.; El-Shafey, M.; Zaitone, S.A. Carbamazepine alleviates retinal and optic nerve neural degeneration in diabetic mice via nerve growth factor-induced PI3K/Akt/mTOR activation. Front. Neurosci. 2019, 13, 1089.
|
[22] |
Mei, Z.H.; Yang, J.; Wang, W.; Cao, P.; Yang, Y.; Li, P.F.; Zhu, K.F.; Jiang, T.; Zhang, M.T. Exploring the effect of choroidalin injection on early diabetic retinopathy based on PI3K/Akt pathway. J. Chin. Med. Eye Ear Nose Throat. 2020, 10, 6–10.
|
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||